Arian
Mossanenzadeh

Mr. Mossanenzadeh’s notable transactions include representing:

• Atalaya Capital Management in its pending $800 million sale to Blue Owl Capital;
• Viatris in its global research and development collaboration with Idorsia;
• CymaBay Therapeutics in its $4.3 billion acquisition by Gilead Sciences;
• Martin Marietta in its $2.05 billion acquisition of aggregates operations from Blue Water Industries;
• HCSC in its pending $3.3 billion acquisition of Cigna’s Medicare businesses and CareAllies;
• Ahold Delhaize in the sale of its FreshDirect business to Getir;
• OUTFRONT Media in the C$410 million divestiture of its Canadian business to Bell Media;
• The special committee of the board of directors of EchoStar in the $26 billion combination with DISH Network;
• Light & Wonder in its acquisition of the remaining stake in SciPlay;
• IBM in its acquisition of StepZen;
• Convey Health Solutions in its $1.1 billion take-private acquisition by TPG Capital;
• Schneider Electric in its acquisition of AutoGrid;
• SMBC Aviation Capital in its $6.7 billion acquisition of Goshawk Aviation;
• White Mountains Insurance in its $1.775 billion sale of NSM to Carlyle;
• Taro in its acquisition of Alchemee, formerly The Proactiv Company, from Galderma;
• GreenSky in its $2.24 billion acquisition by Goldman Sachs;
• New Senior in its $2.3 billion acquisition by Ventas; and
• Swvl in its $1.5 billion SPAC combination with Queen’s Gambit.

Mr. Mossanenzadeh was born in Tehran, Iran. He received a B.A. magna cum laude with distinction from the University of Washington in 2008, where he was elected to Phi Beta Kappa, and a J.D. from the University of Virginia School of Law in 2013, where he was a senior editorial board member of the Virginia Journal of International Law. Mr. Mossanenzadeh joined Cravath in 2021 and was elected a senior attorney in 2023. Prior to joining Cravath, he was associated with a law firm in New York.